期刊文献+

PREPARATION OF POLYALKYLCYANOACRYLATE NANOPARTICLES WITH VARIOUS MORPHOLOGIES 被引量:1

PREPARATION OF POLYALKYLCYANOACRYLATE NANOPARTICLES WITH VARIOUS MORPHOLOGIES
原文传递
导出
摘要 The effects of various reaction conditions on the preparation of polyalkylcyanoacrylate (PACA) nanoparticles are studied. The PACA nanoparticles with different crosslinking degrees and morphology are prepared. Addition of crosslinkers can not only adjust the particle size, but also change the morphology of PACA nanoparticles. Moreover, the loose network structure of the PACA nanoparticles with "core/shell-like" morloholozv is investizated by AFM and TEM in detail. The effects of various reaction conditions on the preparation of polyalkylcyanoacrylate (PACA) nanoparticles are studied. The PACA nanoparticles with different crosslinking degrees and morphology are prepared. Addition of crosslinkers can not only adjust the particle size, but also change the morphology of PACA nanoparticles. Moreover, the loose network structure of the PACA nanoparticles with "core/shell-like" morloholozv is investizated by AFM and TEM in detail.
作者 李贺先
出处 《Chinese Journal of Polymer Science》 SCIE CAS CSCD 2011年第3期336-341,共6页 高分子科学(英文版)
基金 supported by the National Natural Science Foundation of China(Nos.20774053,20974056) the Natural Science Foundation of Tianjin(No.033802611)
关键词 NANOPARTICLES BIODEGRADABILITY PACA Network structure Drug carriers. Nanoparticles Biodegradability PACA Network structure Drug carriers.
  • 相关文献

参考文献24

  • 1Kante, B., Couvreur, P., Dubowas-Krack, G., Demeester, C., Guiot, P., Roland, M., Mercier, M. and Speiser, P., J. Pharm. Sci., 1982, 71:786.
  • 2O'Sullivan, C. and Birkinshaw, C., Polym. Degrad. Stab., 2002, 78:7.
  • 3Couvreur, P., Kante, B., Roland, M., Mercier, M. and Speiser, P., J. Pharm. Pharmacol., 1979, 31:331.
  • 4Liu, T. and Shan, G.R., Acta Polymerica Sinica(in Chinese), 2009, (11): 1132.
  • 5Cao, Z.H., Cui, Q.M. and Shan, G.R., Acta Polymerica Sinica(in Chinese), 2007, (12): 1116.
  • 6Alyautdin, R.N., Petrov, V.E., Langer, K., Berthold, A., Kharkevich, D.A. and Kreuter, J., Pharm. Res., 1997, 14:325.
  • 7Soma, C.E., Dubernet, C., Bentolila, D., Benita, S. and Couvreur, P., Biomaterials, 2000, 21:1.
  • 8Storm, G., Belliot, S., Daemen, T. and Lasic, D.D., Adv. Drug. Deliv. Rev., 1995, 17:31.
  • 9Stolnik, S., Ilium, L. and Davwas, S.S., Adv. Drug. Deliv. Rev., 1995, 16:195.
  • 10Kreuter, J., Adv. Drug. Deliv. Rev., 2001, 47:65.

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部